Tweet
There are still no studies that allow to know what it would have happened if the governments had not taken steps after the declaration of the pandemia of flu A (H1N1). But Filipe Froes, pneumologista and adviser of the General-direction of the Health (DGS), believes that " without preparation two would have died to three times more persons ". Numbers of the European Centre for the Prevention and Control of Diseases (ECDC) put Portugal like one of the European countries with bigger tax of mortality for flu A. It passes today one year since the first cases were known in Mexico. The disease affected 214 countries, 17.798 deaths were confirmed in the world, 121 persons died in Portugal. The pneumologista believes what they had not been taken steps of precaution there would have been more deaths and more resources of health spent. The evaluation of the DGS is still passing but Filipe Froes remembers that the persons who died were young - the average of ages was 47,7 years - and a fifth one they were healthy. Counting what they should survive at least even to 70 years, it is possible to write up " 2843 potential lost years of life ", it underlines.
Numbers of the ECDC put Portugal like one of the countries with worse taxes of mortality for flu A, even so you go down: from 0,91 to 1,2 deaths for 100 thousand inhabitants, face to countries like Spain, France and Italy, where one was for the 0,31 to 0,6 deaths for 100 thousand inhabitants. The subdirectora-general one of the Health, Grace Freitas, says that it is still early to know if these numbers translate real differences of mortality and not different taxes of detection and notification. On the other side, it notices that the numbers are so small that the comparison becomes statistically difficult.
It is going to take some time to realize if different taxes of vaccination were translated in fewer deaths. The certain one is that the Scandinavian countries had bigger capacity of vaccination, says Filipe Froes, setting the example of Sweden, where the tax of vaccination walked for 60 per cent and where the numbers of deaths are the lowest, together with Austria. One was Portugal for five per cent of vaccinal covering, it adds. This year can say that the deaths for seasonal flu, which they affect especially older than 75 years, are indetect?veis, notices the specialist in public health of the DGS, M?rio Carreira. This because 99 per cent of the samples noticed the presence of the H1N1. Grace Freitas refuses the accusation of excess of zeal and it uses the image of the insurance of fire that if he pays every year waiting that the house never burns. We must be satisfied because the virus was not aggressive. Besides, the governments had capacity to get organized. Where Grace Freitas judges what is necessary to improve is in the communication.
Conventional newspapers, TV was measuring with them, radio even ran well, but where they circulated the strangest news, on the vaccines, was in blogues anonymous, in the YouTube, Facebook, Twitter. We have much that to learn, he says. Ant?nio Vaz Carneiro, director of the Centre of Study of Medicine Based on the Evidence, does not doubt of what the measures reduced the mortality affirms them to me what is necessary to measure risks and to consider decisions, because the resources in health are finite. The impact of the vaccine is because of making calculations but Vaz Carneiro appreciates what in order that a life escapes would be necessary to vaccinate between 80 to 100 thousand Portugueses, which is great. At the same time, the doctor PENsa whom, in terms of the communication, the flu A must serve of case study from which it is not necessary to do, beginning for the World-wide Organization of Health and for the national hyper-reactions. It was liking what the science was helping to be less emotional, he unburdens himself. On the other side, the supply of vaccines against the flu A has been helping in the increase of the receipts of some of the biggest laboratories.
Between January and March of this year, the profits of the Swiss group Novartis grew 49 per cent and the sales 25 per cent, over 2200 million euros - 300 million euros above the predicted one for the pharmacist. More than 826 million euros were due to the vaccines against the H1N1. The GlaxoSmithKline, which supplied the vaccine the Portugal, was different of the laboratories that more profited by the sale of new products against the flu. Only between October and December of 2009 it supplied 130 million doses of vaccines for the H1N1. In last year, the sales of this vaccine were translated in an added profit for 1020 million euros for the receipts of the British group, for besides almost 832 millions with the anti-viral Relenza. *
Numbers of the ECDC put Portugal like one of the countries with worse taxes of mortality for flu A, even so you go down: from 0,91 to 1,2 deaths for 100 thousand inhabitants, face to countries like Spain, France and Italy, where one was for the 0,31 to 0,6 deaths for 100 thousand inhabitants. The subdirectora-general one of the Health, Grace Freitas, says that it is still early to know if these numbers translate real differences of mortality and not different taxes of detection and notification. On the other side, it notices that the numbers are so small that the comparison becomes statistically difficult.
It is going to take some time to realize if different taxes of vaccination were translated in fewer deaths. The certain one is that the Scandinavian countries had bigger capacity of vaccination, says Filipe Froes, setting the example of Sweden, where the tax of vaccination walked for 60 per cent and where the numbers of deaths are the lowest, together with Austria. One was Portugal for five per cent of vaccinal covering, it adds. This year can say that the deaths for seasonal flu, which they affect especially older than 75 years, are indetect?veis, notices the specialist in public health of the DGS, M?rio Carreira. This because 99 per cent of the samples noticed the presence of the H1N1. Grace Freitas refuses the accusation of excess of zeal and it uses the image of the insurance of fire that if he pays every year waiting that the house never burns. We must be satisfied because the virus was not aggressive. Besides, the governments had capacity to get organized. Where Grace Freitas judges what is necessary to improve is in the communication.
Conventional newspapers, TV was measuring with them, radio even ran well, but where they circulated the strangest news, on the vaccines, was in blogues anonymous, in the YouTube, Facebook, Twitter. We have much that to learn, he says. Ant?nio Vaz Carneiro, director of the Centre of Study of Medicine Based on the Evidence, does not doubt of what the measures reduced the mortality affirms them to me what is necessary to measure risks and to consider decisions, because the resources in health are finite. The impact of the vaccine is because of making calculations but Vaz Carneiro appreciates what in order that a life escapes would be necessary to vaccinate between 80 to 100 thousand Portugueses, which is great. At the same time, the doctor PENsa whom, in terms of the communication, the flu A must serve of case study from which it is not necessary to do, beginning for the World-wide Organization of Health and for the national hyper-reactions. It was liking what the science was helping to be less emotional, he unburdens himself. On the other side, the supply of vaccines against the flu A has been helping in the increase of the receipts of some of the biggest laboratories.
Between January and March of this year, the profits of the Swiss group Novartis grew 49 per cent and the sales 25 per cent, over 2200 million euros - 300 million euros above the predicted one for the pharmacist. More than 826 million euros were due to the vaccines against the H1N1. The GlaxoSmithKline, which supplied the vaccine the Portugal, was different of the laboratories that more profited by the sale of new products against the flu. Only between October and December of 2009 it supplied 130 million doses of vaccines for the H1N1. In last year, the sales of this vaccine were translated in an added profit for 1020 million euros for the receipts of the British group, for besides almost 832 millions with the anti-viral Relenza. *
